At Reistone, we devised our clinical development strategy around three key pillars: Science, People and Process.
Pursue the best science:
We strive to develop a robust portfolio of clinical ready and clinical-stage breakthrough medicines with novel modes of action building on rigorous scientific foundation.
Empowered passionate people:
Reistone has built a strong clinical development team with highly capable and rich clinical development experience in both global and China clinical trials.
Reistone has built solid internal processes ensuring seamless and collaborative working across multi-functions. End to end processes are ready to ensure the right development strategy, high quality study design, vendor selection, management, efficient study monitoring and quality assurance, etc.